{"id":"W3181643986","doi":"10.3389/fimmu.2021.707463","title":"Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies","year":2021,"lang":"en","type":"article","venue":"Frontiers in Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Université Laval","funders":"","keywords":"Medicine; Tolerability; Confidence interval; Clinical endpoint; Adverse effect; Primary immunodeficiency; Incidence (geometry); Internal medicine; Pediatrics; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004110304,0.0003047538,0.001114013,0.0001575185,0.0002470267,0.000009880375,0.0004352876,0.0003477699,0.0001584163],"category_scores_gemma":[0.0002625811,0.0002377192,0.0002769564,0.0003925421,0.001419093,0.00007131769,0.0001208456,0.000213733,0.000005890293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001645108,"about_ca_system_score_gemma":0.0005267279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005476146,"about_ca_topic_score_gemma":0.00001354649,"domain_scores_codex":[0.997668,0.0002721657,0.001022577,0.0004419082,0.00005214036,0.0005431853],"domain_scores_gemma":[0.9979604,0.0007306435,0.0003473953,0.0008003964,0.0001543961,0.000006775779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008265876,0.002997962,0.00300235,0.0001123754,0.00142805,0.000004565975,0.01237463,0.0002812406,0.2651517,0.001518368,0.0003974308,0.7044655],"study_design_scores_gemma":[0.02367349,0.003970822,0.3598495,0.0001580512,0.0004384621,0.0001622077,0.0148501,0.00007834985,0.1701256,0.001710143,0.4242286,0.0007546823],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4944789,0.497878,0.004548663,0.0003175914,0.001627544,0.0006835434,0.00006848201,0.00002370638,0.0003735657],"genre_scores_gemma":[0.9741126,0.02100149,0.001227705,0.00005026452,0.000006433062,0.00005866792,0.000206888,0.00002875142,0.00330719],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7037108,"threshold_uncertainty_score":0.9693908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01113338574928248,"score_gpt":0.2212691994767696,"score_spread":0.2101358137274871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}